文静的思真
Lv11
10 积分
2024-01-11 加入
-
Development of CpG oligodeoxynucleotide TLR9 agonists in anti-cancer therapy
1小时前
已完结
-
Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: Recent advancements
17天前
已完结
-
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
18天前
已完结
-
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
18天前
已完结
-
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
26天前
已完结
-
DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation
11个月前
已完结
-
Cancer statistics, 2020
11个月前
已完结
-
Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
11个月前
已完结
-
Therapy for osteosarcoma: where do we go from here?
11个月前
已完结
-
The 2021 WHO classification of tumours of the central nervous system
1年前
已关闭